Abstract_ A prophylactic regime of subcutaneous low-dose heparin for the 1st month, followed by warfarin for the 2nd and 3 rd months after spinal cord injury resulted in a dramatic reduction in the incidence of venous thrombosis and pulmonary embolism.
IN 1968 and again in 1974 I reported in our journal Paraple g ia and at this meeting, a survey of 15 years' experience in the management of spinal cord injury with special reference to the incidence of venous thrombosis and pulmonary embolism.
I recorded that there had been an increase over that period in the incidence of venous thrombosis from 12� to 17 per cent, of pulmonary embolism from 5 to 10 per cent, and of mortality from I! to 2t per cent (see Table I ).
At the time of reporting I did not consider that our incidence of complications justified any change of treating the complications with anti-coagulants as soon as they were detected, but without prophylactic therapy. Our decision seemed justified at that time as the next year, 1973, proved to be a year of very low incidence of venous thrombosis, only 6 per cent, but the only death in that year was a youth of 19 with a complete dorsal injury, who died suddenly in the 2nd week with a mas sive pulmonary embolism. This unfortunate death in a fit young person was followed by a year, 1974, in which the incidence of complications rose higher than ever before to 20 per cent with three deaths, a mortality of 6 per cent, all sudden deaths in elderly tetraplegics (see Table II ).
At this time the results of a world wide multi-centre trial of subcutaneous low-dose heparin published in the Lancet proved conclusively that the incidence of 1958 -67 1968 -72 197 3-74 Heparin 1975 venous thrombosis in postoperative patients was greatly reduced by prophylactic anti-coagulant therapy.
Hachen, at our meeting in 1974, had already given evidence that the incidence of venous thombosis and pulmonary embolism had been greatly reduced in cases of spinal cord injury, given low dose subcutaneous heparin followed by oral anti coagulants.
I decided that from the 1st day of 1975 all patients with a recent spinal cord injury would be treated prophylactically from the 1st day of admission. There have been no exceptions to the regime. Our method is to give subcutaneous heparin 5000 units twice daily for a month. During the 4th week all patients are gradually started on warfarin so that by the time the heparin is stopped, the warfarin is being given in therapeutic dosage to keep the prothrombin time between two to three times normal. The warfarin is continued for 2 months so that the average patient is getting mobilised from bed to chair at the end of the 3rd month when the anti-coagulant therapy is stopped.
There have been no complications, local or general from the subcutaneous low-dose heparin. The warfarin therapy similarly has caused few problems, but the dosage required has varied greatly from I to 9 mg daily. We take care not to administer any drugs liable to interfere with the action of warfarin.
I must, however, report the death of one patient, a high tetraplegic of 34 years, who died in the 8th week from intra-abdominal haemorrhage while on warfarin and whose prothrombin time was within agreed limits of twice normal.
Naturally all acute cases undergo the same routine paraplegic management of 2-hourly turns, physiotherapy, catheterisation and regular bowel evacuation. All nursing and physiotherapy staff are on constant watch for alteration in the size and shape of the legs which are measured regularly. The Sonicaid ultra-sound apparatus is used to confirm or refute any clinical signs of thrombosis. If throm bosis occurs while on subcutaneous low-dose heparin, then full treatment with normal doses of heparin followed by warfarin would be instituted.
The results have been dramatic. During the first year, 1975, I had not a single case of thrombosis until the last month of the year when one patient de veloped a partial block of the left femoral vein. This young man had an incomplete paraplegia associated with head, chest and abdominal injuries which I suspected contributed to his thrombosis. He returned to his university studies with an almost normal gait.
The year 1976 was not quite as successful, four cases of thrombosis occurring, but two of these were minor and caused only partial blockage of the femoral vein.
The rema w ng cases developed major complications of venous thrombosis and pulmonary embolism in the 2nd week. One was a youth of 16 years who recovered rapidly from his embolic episode and who later had no residual oedema of the legs. The other was a huge fat man who had ankylosing spondulitis with a fracture dislocation of the cervical spine and complete quadriplegia. He had a massive pulmonary embolism in the 2nd week with cardiac arrest, but recovered well. On reflection we considered that the 5000 units of heparin was quite inadequate for such a gross person. He was the only patient to have been nursed in a S-M Egerton electric bed in a 5-year period in our Unit.
Table III confirms our previous experience that in the pre-heparin era there is a higher incidence of complications in complete than incomplete lesions, that there is a higher incidence in dorsal lesions that at other levels, and that most deaths occurred in cervical injuries. In the post-heparin era the incidence of complica tions is so low that analysis is not required.
With regard to the site of the thrombosis, 70 per cent were in the left leg, 10 per cent in the pelvic veins and 20 per cent could not be identified, but there were none in the right leg, in accordance with our previous findings (see Table IV ). The complications occurred within a month in 90 per cent of cases, the 2nd or 3rd week being the most common time after injury, again in support of our previous observations (Table V) .
Pulmonary embolism occurred commonly without prior warning of venous thrombosis in over 70 per cent of cases as I described previously (Table VI) .
Our results demonstrate the efficacy of routine prophylactic anti-coagulant therapy with low-dose subcutaneous heparin in recent spinal cord injuries. We found that the therapy could be given to all patients without exception and that no complications occurred.
SUMMARY
After many years of a routine of management in which venous thrombosis and pulmonary embolism were treated vigorously after they had occurred, the Sheffield Unit changed to a prophylactic regime using subcutaneous low-dose heparin for the 1st month and warfarin for the 2nd and 3rd months, with a dramatic reduction in the incidence of complications. 
ZUSAMMENFASSUNG
Nach vielen Jahren einer Routinebehandlung, in der venose Thrombose und pul monarer Embolismus stark behandelt wurden, nach dem sie aufgetreten waren, wechselte das Krankenhaus in Sheffield zu einer prophylaktischen Behandlung iiber, in dem man einen Monat lang kleine Dosen Heparin und im zweiten und dritten Monat Warfarin gab, Dadurch wurden komplikationen erheblich reduziert.
